Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1993 | 12-1992 | 09-1992 | 06-1992 | 03-1992 | |
| Sales | 934 | 3,618 | 2,182 | 1,119 | 1,466 |
| Cost of Goods | 0 | 2,372 | 1,984 | 1,690 | 1,219 |
| Gross Profit | 350 | 678 | -439 | -1,220 | -138 |
| Operating Expenses | 3,061 | 1,159 | 1,397 | 1,028 | 678 |
| Operating Income | -2,127 | 459 | -215 | -909 | -212 |
| Interest Expense | 8 | 10 | 10 | 12 | 12 |
| Pre-tax Income | -2,135 | 450 | -226 | -920 | -224 |
| Net Income Continuous | -2,135 | 450 | -226 | -920 | -224 |
| Net Income Discontinuous | 0 | -1,998,000 | -1,998,000 | -1,998,000 | -1,998,000 |
| Net Income | $-2,135 | $450 | $-226 | $-920 | $-224 |
| EPS Basic Total Ops | -0.04 | 0.01 | -0.01 | -0.02 | -0.01 |
| EPS Basic Continuous Ops | -0.04 | 0.01 | 0.00 | -0.02 | 0.00 |
| EPS Basic Discontinuous Ops | N/A | -44.40 | -39.20 | -39.07 | -42.58 |
| EPS Diluted Total Ops | -0.04 | 0.01 | -0.01 | -0.02 | -0.01 |
| EPS Diluted Continuous Ops | -0.04 | 0.01 | 0.00 | -0.02 | 0.00 |
| EPS Diluted Discontinuous Ops | N/A | -39.32 | -39.31 | -39.07 | -39.07 |
| EBITDA(a) | $-2,127 | $459 | $-215 | $-909 | $-212 |